Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003527838 | SCV004328754 | uncertain significance | Mosaic variegated aneuploidy syndrome 2 | 2023-08-27 | criteria provided, single submitter | clinical testing | An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with CEP57-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 27 of the CEP57 protein (p.Ser27Arg). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004369453 | SCV004925584 | uncertain significance | Inborn genetic diseases | 2023-09-29 | criteria provided, single submitter | clinical testing | The c.81C>A (p.S27R) alteration is located in exon 2 (coding exon 2) of the CEP57 gene. This alteration results from a C to A substitution at nucleotide position 81, causing the serine (S) at amino acid position 27 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |